Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening

R Bobrovs, I Kaņepe, N Narvaiss, L Patetko, G Kalniņš, M Sisovs, A.L Bula, S Grīnberga, M Borodušķis, A Ramata-Stunda, N Rostoks, Aigars Jirgensons, K Tārs, K Jaudzems

Experimental details

Pieteikuma datums
30.11.2021.
Atslēgas vārdi
SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors
Hipersaite
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705538/#app1-pharmaceuticals-14-01243